← Back to Patent Explorer
US5234680A Expired / Lapsed US ⏱️ 0.0 years remaining

Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI

Assignee: Towson State University
•
Filing: 1991-09-19
•
Granted: 1993-08-10
•
Expires: 2011-09-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is directed to biological compounds derivatized so as to contain at least one perfluoro-t-butyl moiety for use in fluorine-19 NMR and/or MRI studies. The perfluoro-t-butyl (PFTB) moiety, <IMAGE> is an excellent reporter group for fluorine-19 NMR/MRI. It is a source of nine magnetically equivalent fluorine nuclei which generate a single intense resonance for easy detection in spectroscopy or imaging. This signal is a sharp singlet, not split by neighboring nuclei or spread over a wide frequency range and eliminates any chance of ghost images which might arise from multiple resonances. These spectral properties ensure a maximum signal-to-noise ratio (S/N) for readily detecting this moiety. The foregoing allows either reduction in the concentration of the derivatized compound, ability to use MRI instruments with lower field strengths, a reduction in imaging times, or a combination of the foregoing as a result of this moiety producing a single, sharp, intense resonance. Additionally, the PFTB moiety-containing compounds may be utilized to determine oxygen concentration in aqueous solutions present in animate and inanimate objects.

Inventors

  • 👤 Walter J. Rogers, Jr.
  • 👤 Thomas S. Everett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:06
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/06; Y; Y10; Y10T; Y10T436/00; Y10T436/24

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 96 words
A method of NMR imaging or spectroscopy comprising administering to a subject a composition comprising a derivatized host compound and a carrier for said derivatized host compound, wherein said derivatized host compound is a host compound derivatized so as to contain at least one perfluoro-t-butyl moiety, each of said at least one perfluoro-t-butyl moiety having nine (9) magnetically equivalent fluorine nuclei which generate a single, intense resonance for easy detection in said imaging or spectroscopy, wherein said host compound is a host molecule selected from the group consisting of natural plasma components and brain perfusion agents.
Claim 2
Independent Claim 96 words
A method of NMR imaging or spectroscopy comprising administering to a subject a composition comprising a derivatized host compound and a carrier for said derivatized host compound, wherein said derivatized host compound is a host compound derivatized so as to contain at least one perfluoro-t-butyl moiety, each of said at least one perfluoro-t-butyl moiety having nine (9) magnetically equivalent fluorine nuclei which generate a single, intense resonance for easy detection in said imaging or spectroscopy, wherein said host compound is a host molecule selected from the group consisting of natural plasma components and brain perfusion agents.
Claim 3
Dependent Claim 61 words
A composition for use in NMR imaging and spectroscopy, said composition comprising: a derivatized biological compound, wherein said derivatized biological compound is a host biological molecule derivatized so as to contain at least one perfluoro-t-butyl moiety, said host biological molecule selected from the group consisting of natural plasma components and brain perfusion agents, and a carrier for said derivatized biological compound.
Claim 4
Dependent Claim 61 words
A composition for use in NMR imaging and spectroscopy, said composition comprising: a derivatized biological compound, wherein said derivatized biological compound is a host biological molecule derivatized so as to contain at least one perfluoro-t-butyl moiety, said host biological molecule selected from the group consisting of natural plasma components and brain perfusion agents, and a carrier for said derivatized biological compound.
Claim 5
Dependent Claim 14 words
The composition of claim 2, wherein said host biological molecule is a plasma component.
Claim 6
Dependent Claim 25 words
The composition of claim 3, wherein said plasma component is selected from the group consisting of erythrocytes, leucocytes, platelets, serum albumin, fibrinogen, neutrophiles and prothrombin.
Claim 7
Dependent Claim 15 words
The composition of claim 2, wherein said host biological molecule is a brain perfusion agent.
Claim 8
Dependent Claim 13 words
The composition of claim 5, wherein said brain perfusion agent is n-isopropyl-p-iodoamphetamine hydrochloride.
Claim 9
Dependent Claim 22 words
The method of claim 1, wherein said host compound is a biological host molecule selected from the group consisting of plasma components.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-08-09 1997-02-08 1997-08-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-08-09 2001-02-08 2001-08-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-08-09 2005-02-08 2005-08-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag